Brief: Epigenomics AG expects 2017 revenues to be in range of Euro 1 mln to Euro 1.5 mln
06/07/2017 22:13
July 6 (Reuters) - Epigenomics AG ECXn.DE :
* Epigenomics AG issues change in guidance for financial
year 2017
* Epigenomics ag says now expects 2017 group revenues to be
in range of eur 1.0 to 1.5 million
* Fy adjusted ebitda loss is expected to be in range of eur
12.5 to 14.0 million
Source text for Eikon: ID:nEQ285vnQa
Further company coverage: ECXn.DE
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns